UBS AM
ASTH icon

UBS AM’s Astrana Health ASTH Stock Holding History

UBS AM’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.98M Sell
85,804
-8,923
-9% -$321K ﹤0.01% 1720
2026
Q1 		$2.32M Buy
94,727
+10,015
+12% +$237K ﹤0.01% 1966
2025
Q4 		$2.1M Sell
84,712
-750
-0.9% -$19.9K ﹤0.01% 1864
2025
Q3 		$2.42M Sell
85,462
-72,977
-46% -$1.98M ﹤0.01% 1666
2025
Q2 		$3.94M Buy
158,439
+54,333
+52% +$1.53M ﹤0.01% 1820
2025
Q1 		$3.23M Sell
104,106
-552
-0.5% -$18.4K ﹤0.01% 1779
2024
Q4 		$3.3M Buy
104,658
+14,138
+16% +$671K ﹤0.01% 1807
2024
Q3 		$5.24M Buy
90,520
+2,778
+3% +$136K ﹤0.01% 1543
2024
Q2 		$3.56M Buy
87,742
+36,934
+73% +$1.46M ﹤0.01% 1685
2024
Q1 		$2.13M Hold
50,808
– – ﹤0.01% 1664
2023
Q4 		$1.95M Buy
50,808
+3,807
+8% +$127K ﹤0.01% 1705
2023
Q3 		$1.45M Buy
47,001
+1,914
+4% +$66K ﹤0.01% 1773
2023
Q2 		$1.64M Hold
45,087
– – ﹤0.01% 1765
2023
Q1 		$1.64M Buy
45,087
+1,698
+4% +$59.4K ﹤0.01% 1765
2022
Q4 		$1.28M Buy
43,389
+5,790
+15% +$186K ﹤0.01% 1728
2022
Q3 		$1.47M Sell
37,599
-4,028
-10% -$184K ﹤0.01% 1756
2022
Q2 		$1.61M Buy
41,627
+3,550
+9% +$135K ﹤0.01% 1719
2022
Q1 		$1.85M Buy
38,077
+597
+2% +$30.8K ﹤0.01% 1830
2021
Q4 		$2.75M Buy
37,480
+12,375
+49% +$1.02M ﹤0.01% 1720
2021
Q3 		$2.29M Buy
25,105
+3,624
+17% +$308K ﹤0.01% 1776
2021
Q2 		$1.35M Sell
21,481
-3,400
-14% -$126K ﹤0.01% 2037
2021
Q1 		$674K Buy
24,881
+9,300
+60% +$224K ﹤0.01% 2275
2020
Q4 		$285K Buy
15,581
+3,400
+28% +$61.1K ﹤0.01% 2425
2020
Q3 		$219K Hold
12,181
– – ﹤0.01% 2385
2020
Q2 		$201K Sell
12,181
-1,500
-11% -$23.6K ﹤0.01% 2386
2020
Q1 		$177K Buy
13,681
+1,201
+10% +$19.6K ﹤0.01% 2309
2019
Q4 		$230K Buy
+12,480
New +$207K ﹤0.01% 2443

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS AM's ASTH Position: Q2 2026 in Review

UBS AM reduced its Astrana Health (ASTH) stake by 9.4% in Q2 2026, selling an estimated $321K and leaving 85,804 shares worth $3.98M. The position accounts for ﹤0.01% of the portfolio, ranked #1720.

UBS AM first reported a position in ASTH in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.24M in Q3 2024. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • UBS AM held 85,804 shares of Astrana Health worth $3.98M as of Q2 2026.
  • UBS AM sold 8,923 Astrana Health shares in Q2 2026, an estimated $321K.
  • Astrana Health made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1720 holding.
  • UBS AM first reported a position in Astrana Health in Q4 2019 and has held it in 27 quarters since.
  • UBS AM's Astrana Health position peaked at $5.24M in Q3 2024.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.